Inhibitory effects of inhaled complex traditional Chinese medicine on early and late asthmatic responses induced by ovalbumin in sensitized guinea pigs

BMC Complementary and Alternative Medicine

Oi-Tong Mak³  Ji-Liang Chen⁴  Cheng-Chung Gong¹  Hung-Chou Chang² 

[1] Department of Medical Technology, Chung Hwa University of Medicine Technology, Tainan 717, Taiwan;Office of the Principal, Tainan Tzu-Chi Senior High School, Tainan 708, Taiwan;Department of Healthcare Department, University of Kang Ning, Tainan 709, Taiwan;Department of Life Sciences, National Cheng Kung University, Tainan 701, Taiwan

关键词: ovalbumin;    nebulization;    guinea pig;    Chinese medicine;    asthma;   

Others  :  1232968
DOI  :  10.1186/1472-6882-11-80

 received in 2011-03-21, accepted in 2011-09-24,  发布年份 2011

【 摘 要 】

Background

Many formulae of traditional Chinese medicines (TCMs) have been used for antiasthma treatment dating back many centuries. There is evidence to suggest that TCMs are effective as a cure for this allergenic disease administered via gastric tubes in animal studies; however, their efficacy, safety and side effects as an asthmatic therapy are still unclear.

Methods

In this study, guinea pigs sensitized with ovalbumin (OVA) were used as an animal model for asthma challenge, and the sensitization of animals by bronchial reactivity to methacholine (Mch) and the IgE concentration in the serum after OVA challenge were estimated. Complex traditional Chinese herbs (CTCM) were administered to the animals by nebulization, and the leukocytes were evaluated from bronchoalveolar lavage fluid (BALF).

Results

The results showed that inhalation of CTCM could abolish the increased lung resistance (13-fold increase) induced by challenge with OVA in the early asthmatic response (EAR), reducing to as low as baseline (1-fold). Moreover, our results indicated higher IgE levels (range, 78-83 ng/ml) in the serum of sensitized guinea pigs than in the unsensitized controls (0.9 ± 0.256 ng/ml). In addition, increased total leukocytes and higher levels of eosinophils and neutrophils were seen 6 hours after challenge, and the increased inflammatory cells were reduced by treatment with CTCM inhalation. The interleukin-5 (IL-5) level in BALF was also reduced by CTCM.

Conclusion

Our findings indicate a novel method of administering traditional Chinese medicines for asthma treatment in an animal model that may be more effective than traditional methods.

【 授权许可】

   
2011 Chang et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Kay AB: Asthma and inflammation. J Allergy Clin Immunol 1991, 87:893-910.
• [2]Santing RE, Olymulder CG, Zaagsma J, Meurs H: Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs. J Allergy Clin Immunol 1994, 93:1021-1030.
• [3]Fireman P: Understanding asthma pathophysiology. Allergy Asthma Proc 2003, 24:79-83.
• [4]Holgate ST, Kay AB: Mast cells, mediators and asthma. Clin Allergy 1985, 15:221-234.
• [5]Spina D, Shah S, Harrison S: Modulation of sensory nerve function in the airways. Trends Pharmacol Sci 1998, 19:460-466.
• [6]Pelikan Z, Pelikan-Filipek M: The late asthmatic response to allergen challenge--Part I. Ann Allergy 1986, 56:414-420.
• [7]Hargreave FE: Late-phase asthmatic responses and airway inflammation. J Allergy Clin Immunol 1989, 83:525-527.
• [8]Kao ST, Chang CH, Chen YS, Chiang SY, Lin JG: Effects of Ding-Chuan-Tang on bronchoconstriction and airway leucocyte infiltration in sensitized guinea pigs. Immunopharmacol Immunotoxicol 2004, 26:113-124.
• [9]Fedan JS, Frazer DG: Influence of epithelium on the reactivity of guinea pig isolated, perfused trachea to bronchoactive drugs. J Pharmacol Exp Ther 1992, 262:741-750.
• [10]Booij-Noord H, Orie NG, De Vries K: Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 1971, 48:344-354.
• [11]Cockcroft DW, Murdock KY: Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol 1987, 79:734-740.
• [12]Hegardt B, Pauwels R, Van Der Straeten M: Inhibitory effect of KWD 2131, terbutaline, and DSCG on the immediate and late allergen-induced bronchoconstriction. Allergy 1981, 36:115-122.
• [13]Clark TJH, Godfrey S, Lee TH, Thomson NC: Asthma. In Asthma. New York: Arnold; 2000:319.
• [14]Kao ST, Lin CS, Hsieh CC, Hsieh WT, Lin JG: Effects of xiao-qing-long-tang (XQLT) on bronchoconstriction and airway eosinophil infiltration in ovalbumin-sensitized guinea pigs: in vivo and in vitro studies. Allergy 2001, 56:1164-1171.
• [15]Kao ST, Yeh TJ, Hsieh CC, Shiau HB, Yeh FT, Lin JG: The effects of Ma-Xing-Gan-Shi-Tang on respiratory resistance and airway leukocyte infiltration in asthmatic guinea pigs. Immunopharmacol Immunotoxicol 2001, 23:445-458.
• [16]Kao ST, Yeh TJ, Hsieh CC, Yeh FT, Lin JG: Effect of San-Ao-Tang on immediate and late airway response and leukocyte infiltration in asthmatic guinea pigs. Immunopharmacol Immunotoxicol 2000, 22:143-162.
• [17]Lewis CA, Broadley KJ: Airway hyper- or hyporeactivity to inhaled spasmogens 24 h after ovalbumin challenge of sensitized guinea-pigs. Br J Pharmacol 1995, 116:2351-2358.
• [18]Toward TJ, Broadley KJ: Early and late bronchoconstrictions, airway hyper-reactivity, leucocyte influx and lung histamine and nitric oxide after inhaled antigen: effects of dexamethasone and rolipram. Clin Exp Allergy 2004, 34:91-102.
• [19]Inman MD, Ellis R, Wattie J, Denburg JA, O'Byrne PM: Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 1999, 21:473-479.
• [20]Leigh R, Ellis R, Wattie J, Southam DS, De Hoogh M, Gauldie J, O'Byrne PM, Inman MD: Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 2002, 27:526-535.
• [21]Volgyesi GA, Tremblay LN, Webster P, Zamel N, Slutsky AS: A new ventilator for monitoring lung mechanics in small animals. J Appl Physiol 2000, 89:413-421.
• [22]Abraham WM, Bourdelais AJ, Sabater JR, Ahmed A, Lee TA, Serebriakov I, Baden DG: Airway responses to aerosolized brevetoxins in an animal model of asthma. Am J Respir Crit Care Med 2005, 171:26-34.
• [23]Chatham M, Bleecker ER, Smith PL, Rosenthal RR, Mason P, Norman PS: A comparison of histamine, methacholine, and exercise airway reactivity in normal and asthmatic subjects. Am Rev Respir Dis 1982, 126:235-240.
• [24]Bhagat RG, Grunstein MM: Comparison of responsiveness to methacholine, histamine, and exercise in subgroups of asthmatic children. Am Rev Respir Dis 1984, 129:221-224.
• [25]Scanlon RT: Asthma: a panoramic view and a hypothesis. Ann Allergy 1984, 53:203-212.
• [26]Leigh R, Ellis R, Wattie JN, Hirota JA, Matthaei KI, Foster PS, O'Byrne PM, Inman MD: Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 2004, 169:860-867.
• [27]Busse PJ, Schofield B, Birmingham N, Yang N, Wen MC, Zhang T, Srivastava K, Li XM: The traditional Chinese herbal formula ASHMI inhibits allergic lung inflammation in antigen-sensitized and antigen-challenged aged mice. Ann Allergy Asthma Immunol 2010, 104:236-246.
• [28]Zhang T, Srivastava K, Wen MC, Yang N, Cao J, Busse P, Birmingham N, Goldfarb J, Li XM: Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma. Phytother Res 2010, 24:1047-1055.
• [29]Hutson PA, Holgate ST, Church MK: The effect of cromolyn sodium and albuterol on early and late phase bronchoconstriction and airway leukocyte infiltration after allergen challenge of nonanesthetized guinea pigs. Am Rev Respir Dis 1988, 138:1157-1163.
• [30]Matsumoto T, Ashida Y, Tsukuda R: Pharmacological modulation of immediate and late airway response and leukocyte infiltration in the guinea pig. J Pharmacol Exp Ther 1994, 269:1236-1244.
• [31]Tedeschi E, Menegazzi M, Yao Y, Suzuki H, Forstermann U, Kleinert H: Green tea inhibits human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha activation. Mol Pharmacol 2004, 65:111-120.
• [32]Mariotto S, Esposito E, Di Paola R, Ciampa A, Mazzon E, de Prati AC, Darra E, Vincenzi S, Cucinotta G, Caminiti R, et al.: Protective effect of Arbutus unedo aqueous extract in carrageenan-induced lung inflammation in mice. Pharmacol Res 2008, 57:110-124.
• [33]De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, De Vries K: Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985, 131:373-376.
• [34]Diaz P, Gonzalez MC, Galleguillos FR, Ancic P, Cromwell O, Shepherd D, Durham SR, Gleich GJ, Kay AB: Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am Rev Respir Dis 1989, 139:1383-1389.
• [35]Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW: Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 1986, 89:477-483.
• [36]Beasley R, Roche WR, Roberts JA, Holgate ST: Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989, 139:806-817.
• [37]Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000, 105:651-663.
• [38]Wu W, Samoszuk MK, Comhair SA, Thomassen MJ, Farver CF, Dweik RA, Kavuru MS, Erzurum SC, Hazen SL: Eosinophils generate brominating oxidants in allergen-induced asthma. J Clin Invest 2000, 105:1455-1463.
• [39]Busse WW: The role of leukotrienes in asthma and allergic rhinitis. Clin Exp Allergy 1996, 26:868-879.
• [40]Lee T, Lenihan DJ, Malone B, Roddy LL, Wasserman SI: Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem 1984, 259:5526-5530.
• [41]Chung KF, Barnes PJ: Cytokines in asthma. Thorax 1999, 54:825-857.
• [42]Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, Hogan SP, Koskinen A, McKenzie AN, Dent LA, et al.: Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 2002, 195:1433-1444.
• [43]Fahy JV, Kim KW, Liu J, Boushey HA: Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995, 95:843-852.
• [44]Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ: Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999, 160:1532-1539.
• [45]Macdowell AL, Peters SP: Neutrophils in asthma. Curr Allergy Asthma Rep 2007, 7:464-468.